Calculus Creative Content EIS Fund celebrated its first year and made its fifth investment into Home Team. Netflix recently announced it will boost its spend on making TV shows in the UK to $1bn next year, further proof that the … Continued
Archives for 2020
C4X Discovery Holdings plc, a pioneering Drug Discovery company, confirms that Clive Dix, Chief Executive Officer of C4XD has stepped into the role of Interim Chair of the UK Vaccine Taskforce, the group set up by the Government to lead … Continued
Earlier this year Wonderhood was appointed the creative account to Branston owner Mizkan. They have released their first TV advert for Branston, to critical acclaim. Campaign called the ad “heartwarming” when awarding it the ‘Ad of the Day.’ Little Black … Continued
Streaming giant ups budget by 50% as Disney also invests in production facilities at Pinewood Studios Netflix will boost its spend on making TV shows in the UK to $1bn (£750m) this year as the streaming giant maintains the breakneck pace … Continued
At a time when the pandemic has challenged so many established business models, entertainment, predominantly home entertainment, is one of the few sectors continuing to grow and the screen industry is one of the fastest growing sectors in the UK. … Continued
Normal initial fees of 3-5% waived until end of December Award-winning Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist, Calculus Capital, is waiving initial fees on its VCT until the end of November. The VCT is aiming to deliver … Continued
Mo enables individuals, teams and organisations to capture, celebrate and elevate moments at work by becoming the destination for people to share and engage in what is meaningful to them at work. Mo believes meaningful moments have the power to … Continued
Calculus has long been a supporter of the life sciences sector. In April we wrote about how many of our healthcare companies had quickly pivoted their resources to help play their part in the fight against COVID-19. Over the past … Continued
Open Orphan/hVIVO Signs Contract with UK Government for the Development of a COVID-19 Human Challenge Study Model COVID-19 human challenge study model to safely speed up development of an efficacious vaccine. hVIVO has the world’s leading portfolio of 8 human challenge study models developed … Continued
New agreement to develop and commercialise ready-to-administer medicine The agreement builds on Hikma and Arecor’s first product co-development agreement, which was announced on 9 January 2020 London and Cambridge, October 20, 2020 Hikma Pharmaceuticals PLC (Hikma or the Group), the … Continued
